0.6994
前日終値:
$0.6948
開ける:
$0.7068
24時間の取引高:
269.46K
Relative Volume:
0.28
時価総額:
$41.07M
収益:
-
当期純損益:
$-123.46M
株価収益率:
-0.27
EPS:
-2.59
ネットキャッシュフロー:
$-104.11M
1週間 パフォーマンス:
-7.97%
1か月 パフォーマンス:
+1.67%
6か月 パフォーマンス:
+43.85%
1年 パフォーマンス:
-63.57%
Bioatla Inc Stock (BCAB) Company Profile
BCAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BCAB
Bioatla Inc
|
0.6994 | 40.80M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-13 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-05-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-06-28 | 開始されました | ROTH Capital | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | BTIG Research | Buy |
| 2021-01-11 | 開始されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | JP Morgan | Overweight |
| 2021-01-11 | 開始されました | Jefferies | Buy |
すべてを表示
Bioatla Inc (BCAB) 最新ニュース
Is BioAtla Inc. a candidate for recovery play2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Sentiment analysis tools applied to BioAtla Inc.2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
What to do if you’re stuck in BioAtla Inc.Earnings Growth Report & Technical Pattern Recognition Alerts - newser.com
Will BioAtla Inc. continue its uptrendRate Hike & Safe Entry Point Alerts - newser.com
Why BioAtla Inc. stock is favored by top institutions2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Analyzing BioAtla Inc. with risk reward ratio chartsLayoff News & Verified Short-Term Plans - newser.com
How supply chain issues affect BioAtla Inc. stockAnalyst Upgrade & Weekly High Conviction Ideas - newser.com
Chart overlay techniques for tracking BioAtla Inc.Gold Moves & Low Drawdown Trading Strategies - newser.com
Measuring BioAtla Inc.’s beta against major indicesWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
What moving averages say about BioAtla Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Why BioAtla Inc. stock is a value investor pickWeekly Risk Summary & Advanced Technical Signal Analysis - Fundação Cultural do Pará
BioAtla’s Phase 1 Study on BA3182: A New Hope for Advanced Adenocarcinoma - TipRanks
Can BioAtla Inc. stock sustain institutional interest2025 Big Picture & Capital Protection Trade Alerts - Fundação Cultural do Pará
Bioatla Inc (BCAB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):